Rivaroxaban

Takaitaccen Bayani:

Sunan API Nuni Ƙayyadaddun bayanai Farashin DMF EU DMF CEP
Rivaroxaban Anticoagulant Cikin Gida TDP    


Cikakken Bayani

Tags samfurin

BAYANIN KYAUTA

Fage

Rivaroxaban, 5-chloro-N-[[(5S)-2-oxo-3-[4- (3-oxomorpholin-4-yl) phenyl]-1,3-oxazolidin-5-yl]methyl] thiophene-2 -carboxamide, shine mai hana ƙananan ƙwayoyin ƙwayoyin cuta na factor Xa wanda shine ma'auni na coagulation a wani matsayi mai mahimmanci a cikin hanyar haɗin jini wanda ya haifar da haɓakar thrombin da samuwar jini.Rivaroxaban yana ɗaure zuwa Tyr288 a cikin aljihun S1 na factor Xa ta hanyar hulɗar Tyr288 da chlorine maimakon chlorothiophene moiety.Hani yana iya jujjuyawa (koff = 5x10-3s-1), mai sauri (kon = 1.7x107 mol / L-1 s-1), kuma a cikin hanyar da ta dogara da hankali (Ki = 0.4 nmol / L).A halin yanzu ana nazarin Rivaroxaban don maganin VTE, rigakafin cututtuka na zuciya da jijiyoyin jini a cikin marasa lafiya tare da ciwo mai tsanani, rigakafin bugun jini a cikin marasa lafiya da fibrillation.

Magana

Elisabeth Perzborn, Susanne Roehrig, Alexander Straub, Dagmar Kubitza, Wolfgang Mueck, da Volker Laux.Rivaroxaban: sabon mai hanawa Xa.Arterioscler Thromb Vasc Biol 2010;30 (3): 376-381

Bayani

Rivaroxaban (BAY 59-7939) yana da ƙarfi sosai,Zaɓaɓɓen da kai tsaye Factor Xa (FXa) mai hanawa, samun nasara mai ƙarfi a cikin ƙarfin anti-FXa (IC50 0.7 nM; Ki 0.4 nM).

 

A cikin Vitro

Rivaroxaban (BAY 59-7939) mai hanawa ne na baka, kai tsaye Factor Xa (FXa) mai hanawa a cikin ci gaba don rigakafi da kuma maganin thrombosis na arterial da venous.Rivaroxaban gasa yana hana FXa ɗan adam (Ki 0.4 nM) tare da> 10 000-ninka mafi girman zaɓi fiye da sauran ƙwayoyin cuta na serine;Hakanan yana hana ayyukan prothrombinase (IC50 2.1 nM).Rivaroxaban yana hana FXa endogenous mafi ƙarfi a cikin jini na ɗan adam da zomo (IC50 21 nM) fiye da ƙwayar bera (IC50 290 nM).Yana nuna tasirin anticoagulant a cikin jini na ɗan adam, lokacin prothrombin sau biyu (PT) kuma yana kunna lokaci na thromboplastin a 0.23 da 0.69.μM, bi da bi.

 

Rivaroxaban (BAY 59-7939) mai ƙarfi ne kuma mai zaɓi, mai hana FXa kai tsaye tare da kyakkyawan aiki a cikin vivo da ingantaccen yanayin rayuwa na baka.Rivaroxaban (BAY 59-7939), wanda iv bolus ke gudanarwa kafin shigar da thrombus, yana rage haɓakar thrombus (ED50 0.1 mg/kg), yana hana FXa, kuma yana tsawaita adadin PT dogara.PT da FXa sun shafi dan kadan a ED50 (ƙara 1.8-ninka da 32% hanawa, bi da bi).A 0.3 MG / kg (kashi wanda ke haifar da kusan cikakken hana haɓakar thrombus), Rivaroxaban yana tsawaita PT (3.2) a matsakaici.±0.5-ninka) kuma yana hana ayyukan FXa (65±3%).

 

Ajiya

Foda

-20°C

shekaru 3
 

4°C

shekaru 2
A cikin ƙarfi

-80°C

Wata 6
 

-20°C

Wata 1

Tsarin sinadaran

Rivaroxaban

CERTIFICATION

2018 GMP-2
原料药GMP证书201811(captopril ,thalidomide etc)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Letter-201901

INGANTACCEN KYAUTA

Quality management1

Shawara18Ayyukan Ƙididdigar Ƙirar Ƙirar da aka amince da su4, kuma6ayyukan suna ƙarƙashin amincewa.

Quality management2

Babban tsarin kula da ingancin ingancin ƙasa ya kafa tushe mai ƙarfi don siyarwa.

Quality management3

Ingantacciyar kulawa tana gudanar da duk tsawon rayuwar samfurin don tabbatar da inganci da tasirin warkewa.

Quality management4

Mawakan da ake gudanarwa na kwararru yana tallafawa ingancin bukatun yayin aikace-aikacen da rajista.

SAMUN SARAUTA

cpf5
cpf6

Layin Packaging Bottled na Koriya Countec

cpf7
cpf8

Layin Marufi na CVC Taiwan

cpf9
cpf10

Layin Marufi na Hukumar CAM Italiya

cpf11

Jamus Fette Compacting Machine

cpf12

Japan Viswill Tablet Detector

cpf14-1

Dakin Kulawa na DCS

ABUNCI

Hadin gwiwar kasa da kasa
International cooperation
Hadin kai na cikin gida
Domestic cooperation

  • Na baya:
  • Na gaba:

  • Ku rubuta sakonku anan ku aiko mana

    Rukunin samfuran